Ella Related Published Studies
Well-designed clinical trials related to Ella (Ulipristal)
Ulipristal acetate - safety and pharmacokinetics following multiple doses of
10-50 mg per day. [2013]
Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. [2010.02.13]
Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly
delays follicular rupture. [2010]
Randomised comparison of the FerX Ella antireflux stent and the ultraflex stent: proton pump inhibitor combination for prevention of post-stent reflux in patients with esophageal carcinoma involving the esophago-gastric junction. [2008.05]
Well-designed clinical trials possibly related to Ella (Ulipristal)
Breast-cancer adjuvant therapy with zoledronic acid. [2011.10.13]
Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study. [2011.02]
Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids:
a randomized, double-blind, placebo-controlled, phase IIb study. [2011]
Effect of topical 0.5% morphine on postoperative pain after photorefractive keratectomy. [2010.12]
Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914. [2010.04]
Randomized placebo-controlled trial of CDB-2914 in new users of a levonorgestrel-releasing intrauterine system shows only short-lived amelioration of unscheduled bleeding. [2010.02]
Tailored telephone education to promote awareness and adoption of fruit and vegetable recommendations among urban and mostly immigrant black men: a randomized controlled trial. [2009.01]
Vascular connections of the lateral wall of the sinus: surgical effect in sinus augmentation. [2008.11]
Septa within the sinus: effect on elevation of the sinus floor. [2008.09]
Knowledge, barriers, and stage of change as correlates of fruit and vegetable consumption among urban and mostly immigrant black men. [2008.08]
CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial. [2008.05]
Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic-pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo-controlled trial. [2007.09]
Other research related to Ella (Ulipristal)
[Selective progesterone receptor modulator (ulipristal acetate--a new option in
the pharmacological treatment of uterine fibroids in women]. [Article in Polish] [2013]
Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel. [2011.10]
Ulipristal acetate for emergency contraception. [2011.06]
Ulipristal acetate: contraceptive or contragestive? [2011.06]
Ulipristal acetate: a review of its use in emergency contraception. [2011.05.07]
Ulipristal acetate: a new emergency contraceptive that is safe and more effective than levonorgestrel. [2011.01]
Can we identify women at risk of pregnancy despite using emergency contraception?
Data from randomized trials of ulipristal acetate and levonorgestrel. [2011]
Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture. [2010.09]
Ulipristal acetate for emergency contraception. [2010.09]
Intrauterine administration of CDB-2914 (Ulipristal) suppresses the endometrium of rhesus macaques. [2010.04]
Ulipristal acetate taken 48-120 hours after intercourse for emergency contraception. [2010.02]
Ulipristal acetate versus levonorgestrel for emergency contraception: a
randomised non-inferiority trial and meta-analysis. [2010]
Ulipristal, a progesterone receptor antagonist as a contraceptive and for the treatment of uterine fibroids. [2007.10]
Other possibly related research studies
Multimeric lactoside "click clusters" as tools to investigate the effect of linker length in specific interactions with peanut lectin, galectin-1, and -3. [2010.07.05]
Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients. [2010.05.01]
Treatment of intracranial aneurysms by functional reconstruction of the parent artery: the Budapest experience with the pipeline embolization device. [2010.06]
Total vaginal necrosis: a representative example of underreporting severe late toxic reaction after concomitant chemoradiation for cervical cancer. [2010.01]
A new fully covered stent with antimigration properties for the palliation of malignant dysphagia: a prospective cohort study. [2010.03]
Physiological and computed tomographic predictors of outcome from lung volume reduction surgery. [2010.03.01]
A self-expanding metal stent for complicated variceal hemorrhage: experience at a single center. [2010.01]
[Complex therapy of schizophrenia] [2009.03]
Epithelial removal and phototherapeutic keratectomy for residual refractive error following LASIK in eyes with corneal epithelial basement membrane degeneration. [2009.08]
Single puncture percutaneous nephrolithomy for management of complex renal stones. [2009.04.20]
Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients. [2009.05]
Treatment of upper gastrointestinal leaks with a removable, covered, self-expanding metallic stent. [2009.02]
Polyester nanoparticles presenting mannose residues: toward the development of new vaccine delivery systems combining biodegradability and targeting properties. [2009.03.09]
Development of pilot scale production process and characterization of a recombinant multiepitope malarial vaccine candidate FALVAC-1A expressed in Escherichia coli. [2008.09]
The effects of dietary phenolic compounds on cytokine and antioxidant production by A549 cells. [2008.06]
Prediction of volumetric change in the "triple ring" caused by glioma I-125 brachytherapy. [2008.08]
Impact of aneurysmal geometry on intraaneurysmal flow: a computerized flow simulation study. [2008.05]
Water intoxication-a dangerous condition in labor and delivery rooms. [2007.11]
Effect of infliximab on the glycosylation of IgG of patients with rheumatoid arthritis. [2007]
Long-term results and late complications after intracavitary yttrium-90 colloid irradiation of recurrent cystic craniopharyngiomas. [2007.08]
Induction of lung lesions in Wistar rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its inhibition by aspirin and phenethyl isothiocyanate. [2007.05.29]
The role of microglia/macrophage system in the tissue response to I-125 interstitial brachytherapy of cerebral gliomas. [2007.04]
Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth. [2010.05]
Emergency contraception: update and review. [2010.03]
Clinical utility of progesterone receptor modulators and their effect on the endometrium. [2009.08]
Selective progesterone receptor modulators 2: use in reproductive medicine. [2008.10]
Gateways to clinical trials. [2008.01]
Gateways to clinical trials. [2007.04]
2010 Society for Neuro-Oncology Annual Meeting: a report of selected studies. [2011.02]
Mucin secretion induced by titanium dioxide nanoparticles. [2011.01.19]
Focus on adoptive T cell transfer trials in melanoma. [2010]
Defining reality: the potential role of pharmacists in assessing the impact of progesterone receptor modulators and misoprostol in reproductive health. [2011.01]
Update on emergency contraception. [2011.02]
Feasibility and safety of endoscopic transesophageal access and closure using a Maryland dissector and a self-expanding metal stent. [2011.07]
Efficacy and safety of biodegradable stents for refractory benign esophageal strictures: the BEST (Biodegradable Esophageal Stent) study. [2010.11]
[Inhalation therapy for asthma, and inhalation devices]. [2010]
Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety. [2011.11]
Gateways to clinical trials. [2010.12]
American Society of Clinical Oncology 2011 CNS tumors update. [2011]
Effect of topical 0.5% morphine on postoperative pain after photorefractive
keratectomy. [2010]
Cell-type specific actions of progesterone receptor modulators in the regulation
of uterine leiomyoma growth. [2010]
Randomized placebo-controlled trial of CDB-2914 in new users of a
levonorgestrel-releasing intrauterine system shows only short-lived amelioration
of unscheduled bleeding. [2010]
Endometrial effects of a single early luteal dose of the selective progesterone
receptor modulator CDB-2914. [2010]
Prospective randomized study to assess the efficacy of site and rate of atrial
pacing on long-term progression of atrial fibrillation in sick sinus syndrome:
Septal Pacing for Atrial Fibrillation Suppression Evaluation (SAFE) Study. [2013]
[Applicability of selective progesterone receptor modulators in the treatment of
uterine leiomyomata and their future role in the field of gynecology]. [Article in Polish] [2013]
Efficacy and safety of pain relief medications after photorefractive keratectomy:
review of prospective randomized trials. [2014]
Medical therapy of gliomas. [2014]
|
